Glaukos Corp
(FRA:6GJ)
€
119
0 (0%)
Market Cap: 6.63 Bil
Enterprise Value: 6.53 Bil
PE Ratio: 0
PB Ratio: 10.75
GF Score: 61/100 Glaukos Corp at Citi Healthcare & Medtech Conference Transcript
Mar 01, 2023 / 06:15PM GMT
Release Date Price:
€44.2
(-1.34%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
Well, welcome back after lunch. I'm still Joanne Wuensch, the medical technology analyst here. That has not changed. But these people are new up here. So let me introduce Joe Gilliam, the President and Chief Operating Officer; Alex Thurman, CFO; and Chris Lewis, Vice President, Investor Relations and Corporate Affairs, and they're from Glaukos, in case you don't know.
Questions & Answers
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
So's a lot to talk about, but I think I'm going to go straight to the chase, which is guidance. I'm seeing a lot of pushback on how you decided to put guidance together. So let's start there, how you think about kicking -- building off of the fourth quarter '22 delivery. What the puts and takes were in as you thought about 2023?
Joseph E. Gilliam;Joanne Karen Wuensch
Glaukos Corporation - President & COO;Citigroup Inc.,
Sure. Well, no warm-up question, I guess.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot